Pulse Biosciences Inc (PLSE) Actualités

Form S-8 - Securities to be offered to employees in employee benefit plans

Form S-8 - Securities to be offered to employees in employee benefit plans

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™...

Form 8-K - Current report

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc...

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Nanosecond PFA Percutaneous Electrode System to be highlighted in clinical science and video sessions Pulse Biosciences, Inc. (Nasdaq: PLSE), a...

Form 8-K - Current report

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Successfully treated atrial fibrillation (AF) in initial 30 patients with the Nanosecond PFA 360° Cardiac Catheter Pulse Biosciences, Inc...

Form 8-K - Current report

Form 8-K - Current report

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in late-breaking clinical science session and in a live case transmission...

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Current Co-Chairman of the Board will now also serve as Chief Executive Officer Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse...

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™...

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™...

Form 4 - Statement of changes in beneficial ownership of securities